| BIOCRYST PHARMACEUTICALS |
| USA |
| Gesundheit |
| US09058V1035 / 896047 |
| BO1 (Frankfurt) / BCRX (NASDAQ) |
| FRA:BO1, ETR:BO1, BO1:GR, NASDAQ:BCRX |
| - |
| https://www.biocryst.com/ |
|
BioCryst Pharmaceuticals Inc. is a biotechnology c..
>Volltext.. |
| 1256.9 Mio. EUR |
| 1663.98 Mio. EUR |
| 485.19 Mio. EUR |
| 48.28 Mio. EUR |
| -31.08 Mio. EUR |
| -0.15 EUR |
| 643.07 Mio. EUR |
| 77.04 Mio. EUR |
| 14.41 Mio. EUR |
| 1.47 |
| 32.62% |
| 77.75% |
| - |
| - |
| - |
| - |
| BIOCRYST |
| 05.11.25 |
|
||||
|
||||
|